Form D · Other Health Care
Cardiogen Sciences, Inc.
Palo Alto, CA · CIK 0001626815
Offering snapshot reported Dec 8, 2014 · SEC filing
- Reported sold
- $526K Offering amount: $526K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 6, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 8, 2014 | Initial | $525,795 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-229627
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Dec 8, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Louis G. Lange | Director, Executive |
| Silvia Giuliana Priori | Director |
| Edmund M. Ruffin | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
509 Hale Street
Palo Alto, CA, 94301-2210
Palo Alto, CA, 94301-2210